⬆
X
By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

Comparison results

 
Results: Differences General ✘Soft tissue sarcoma✘Alport syndrome
Related research Analogs Analogs
Register, to see more distinctive signs of diseases and studies 100%(6)100%(2)
Coagulogram 82%(4)46%(3)
General urine test 51%(1)75%(14)
General blood test 64%(5)52%(8)
Histological studies 74%(0)11%(0)
Creatinine clearance 63%(0)7%(0)
Ultrasound of the Heart 53%(0)—
ECG 52%(0)—
Distinctive symptoms
Register, to see more distinctive signs of diseases and studies 70%—
Register, to see more distinctive signs of diseases and studies —91%
fibroma 62% —
inflammation of the kidneys — 63%
likes sweets 56% —
chronic kidney failure — 62%
soft tissue sarcoma 51% —
kidney failure — 60%
liposarcoma 50% —
hearing impaired — 58%
fibrosarcoma 41% —
hematuria 7% 57%
hemorrhagic cystitis 40% —
congestive kidney 7% 53%
metastases 38% —
alport syndrome — 45%
radiation damage 36% —
impaired kidney function 6% 46%
radiation therapy 35% —
diffuse toxic goiter — 31%
paranoia 34% —
thyrotoxicosis — 31%
ewing 's sarcoma 33% —
enlargement of the thyroid gland — 29%
does not tolerate pain 33% —
proteinuria — 29%
suspicion 33% —
glomerulonephritis — 27%
skin problems 46% 12%
microhematuria — 27%
kaposi 's sarcoma 31% —
berger 's disease — 23%
effects of radiation 31% —
chronic kidney disease — 23%
osteosarcoma 31% —
acute glomerulonephritis — 20%
consequences of surgery 29% —
anemia 7% 27%
radiation cystitis 28% —
little urine — 20%
lung cancer 28% —
number of miscarriages is increased — 19%
effects of chemotherapy 27% —
kidney damage — 17%
rhabdomyosarcoma 27% —
deafness — 17%
solid tumors 26% —
urine erythrocytes are elevated — 17%
cystitis 35% 7%
antineutrophilic cytoplasmic antibodies — 17%
metastases to the lungs 26% —
heaviness in the kidneys — 17%
oncology in the anamnesis 36% 9%
clouding of the lens — 17%
angiosarcoma 25% —
pale palate — 16%
malignant lymphoma 24% —
nephropathy 7% 23%
herpes rashes 24% —
end-stage renal failure — 16%
desmoid tumor 24% —
hematuric nephritis — 16%
rash pustules 24% —
hypertension — 15%
lymph node damage 23% —
fine-grained — 15%
lymphoma 23% —
sensorineural — 15%
carcinoid 22% —
visual impairment — 14%
epithelioma 22% —
miscarriage — 14%
lee-fraumeni syndrome 22% —
cataract — 14%
basal 22% —
distortion of vision — 14%
angiosarcoma of the heart 22% —
s eyes cloudy — 13%
breast sarcoma 21% —
aslo is reduced — 13%
benign neoplasms 21% —
bronchitis in childhood — 13%
sensations in the extremities 21% —
cloudy urine — 13%
consequences of taking medications 28% 5%
esophageal cancer — 13%
lung sarcoma 20% —
the onset of the disease during puberty — 13%
herpes 20% —
dislocation of the lens — 13%
there is no herpes 20% —
nephrotic syndrome — 12%
hiv 20% —
antinuclear factor — 12%
cns tumors 20% —
esophageal stenosis — 12%
breast tumor 20% —
abdominal pain in children — 12%
cancer 33% 11%
dyspnea — 12%
neurinoma 19% —
chronic glomerulonephritis — 12%
patient's condition 26% 5%
pain in the esophagus — 12%
cancer in the anamnesis 31% 10%
pain in the eyes — 12%
soft tissue sarcoma in children 18% —
consequences of miscarriage — 12%
malignant hyperthermia 18% —
convulsions — 11%
neurofibroma 18% —
feeling of pressure on the bottom — 11%
brain cancer 18% —
weakness of the eyes — 11%
bone cancer 18% —
periodic abdominal pain — 11%
swelling 25% 5%
exophthalmos — 11%
stage of recovery 17% —
nephritic syndrome — 11%
recovery period 17% —
cyclic vomiting — 11%
hyperthermia 17% —
orbital hypertelorism — 11%
adrenal cancer 17% —
sediment urine — 11%
aggressive 17% —
sagging skin — 11%
breast cancer 17% —
rapidly progressive glomerulonephritis — 11%
protein-energy deficiency 17% —
oxalaturia — 11%
worse in morning 16% —
multiple kidney stones — 11%
better in morning 16% —
kidney transplantation — 11%
bone metastases 16% —
hemorrhagic syndrome — 11%
postoperative scars 16% —
often abdominal pain — 11%
oncology 30% 12%
mucous membranes are pale — 11%
myxoma 15% —
Chronical bronchitis — 10%
many friends 15% —
weakness in the extremities — 10%
vascular tumor 23% 6%
death of relatives — 10%
brain tumors 15% —
vomiting multiple — 10%
recklinghausen 's neurofibromatosis 15% —
death of a loved — 10%
worse lying down 15% —
pain in the sternum — 10%
clear boundaries 15% —
streptodermia — 10%
necrosis 15% —
can not breathe — 10%
head tumor 15% —
j42 chronic bronchitis — 10%
wound 15% —
abdominal pain with vomiting — 10%
angioplasty 14% —
leukocyturia — 10%
surgical infections 14% —
erythrocytosis — 10%
brain tumor 14% —
crystalluria — 10%
oncology relatives 14% —
dislocation — 10%
seminoma 14% —
red blood vessels of the eyes — 10%
heaviness in the extremities 13% —
changes in urine — 10%
bone fracture 13% —
insensitivity to pain — 10%
metastatic brain tumors 13% —
shortness of breath constant — 10%
tumors of peripheral nerves 13% —
nose large eyes — 10%
lipoma 13% —
angiopathy of the retina — 10%
lymphostasis 13% —
ureteral stones — 10%
drug disease 13% —
essential hypertension — 9%
tumors of the adrenal glands 13% —
difficulty breathing — 9%
c22 13% —
acute bronchitis — 9%
significant operational risk 13% —
tumors of the ureter — 9%
blue veins 13% —
feeling of cold in the body — 9%
clumsiness 13% —
cramps in the legs — 9%
scarring 13% —
hemarthrosis — 9%
worse at 7 am 13% —
hemorrhagic vasculitis — 9%
limbs pain 13% —
renal osteodystrophy — 9%

Instructions

Video
  1. Introduce new diseases through 🔍 Search and input on the top panel using
  2. The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
  3. The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
  4. The list changes dynamically depending on the data of the current visit in the selection of therapy .
  5. Click on the percentageto see the suggestions from the original source.
  6. By using the service, you agree to user agreement.